Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs
Publication information:
Jutzi J, Marneth A, Ciboddo M, Guerra-Moreno A, Jiménez-Santos M, Kosmidou A, Dressman J, Liang H, Hamel R, Lozano P, Rumi E, Doench J, Gotlib J, Krishnan A, Elf S, Al-Shahrour F, Mullally A. Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.
Blood. 2022;140(11):1291–1304.